000144698 001__ 144698
000144698 005__ 20240229123020.0
000144698 0247_ $$2doi$$a10.1002/path.5342
000144698 0247_ $$2pmid$$apmid:31465124
000144698 0247_ $$2ISSN$$a0022-3417
000144698 0247_ $$2ISSN$$a0368-3494
000144698 0247_ $$2ISSN$$a1096-9896
000144698 0247_ $$2ISSN$$a1555-2039
000144698 0247_ $$2altmetric$$aaltmetric:65674436
000144698 037__ $$aDKFZ-2019-02140
000144698 041__ $$aeng
000144698 082__ $$a610
000144698 1001_ $$aRoh, Vincent$$b0
000144698 245__ $$aThe transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma.
000144698 260__ $$aBognor Regis [u.a.]$$bWiley$$c2020
000144698 3367_ $$2DRIVER$$aarticle
000144698 3367_ $$2DataCite$$aOutput Types/Journal article
000144698 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1577957279_11638
000144698 3367_ $$2BibTeX$$aARTICLE
000144698 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144698 3367_ $$00$$2EndNote$$aJournal Article
000144698 500__ $$a2020 Jan;250(1):107-119
000144698 520__ $$aSustained expression of FOXM1 is a hallmark of nearly all human cancers including squamous cell carcinomas of the head and neck (HNSCC). HNSCCs partially preserve the epithelial differentiation program, which recapitulates fetal and adult traits of the tissue of tumor origin but is deregulated by genetic alterations and tumor-supporting pathways. Using shRNA-induced knockdown, we demonstrate a minimal impact of FOXM1 on proliferation and migration of HNSCC cell lines under standard cell culture conditions. However, FOXM1 knockdown in three-dimensional (3D) culture and xenograft tumor models resulted in reduced proliferation, decreased invasion and a more differentiated-like phenotype, indicating a context dependent modulation of FOXM1 activity in HNSCC cells. By ectopic overexpression of FOXM1 in HNSCC cell lines, we demonstrate a reduced expression of cutaneous-type keratin K1 and involucrin as a marker of squamous differentiation, supporting the role of FOXM1 in modulation of aberrant differentiation in HNSCC. Thus, our data provide a strong rationale for targeting FOXM1 in HNSCC. This article is protected by copyright. All rights reserved.
000144698 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000144698 588__ $$aDataset connected to CrossRef, PubMed,
000144698 7001_ $$aHiou-Feige, Agnès$$b1
000144698 7001_ $$aMisetic, Vinko$$b2
000144698 7001_ $$aRivals, Jean-Paul$$b3
000144698 7001_ $$aSponarova, Jana$$b4
000144698 7001_ $$aTeh, Muy-Teck$$b5
000144698 7001_ $$aFerreira Lopes, Silvia$$b6
000144698 7001_ $$aTruan, Zinnia$$b7
000144698 7001_ $$aMermod, Maxime$$b8
000144698 7001_ $$aMonnier, Yan$$b9
000144698 7001_ $$0P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f$$aHess, Jochen$$b10$$udkfz
000144698 7001_ $$00000-0002-5560-4157$$aTolstonog, Genrich V$$b11
000144698 7001_ $$aSimon, Christian$$b12
000144698 773__ $$0PERI:(DE-600)1475280-3$$a10.1002/path.5342$$gp. path.5342$$n1$$p107-119$$tThe journal of pathology$$v250$$x1096-9896$$y2020
000144698 909CO $$ooai:inrepo02.dkfz.de:144698$$pVDB
000144698 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000144698 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000144698 9141_ $$y2020
000144698 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000144698 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144698 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144698 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144698 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ PATHOL : 2017
000144698 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144698 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000144698 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144698 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144698 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000144698 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000144698 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144698 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ PATHOL : 2017
000144698 9201_ $$0I:(DE-He78)A102-20160331$$kA102$$lMolekulare Grundlagen von HNO-Tumoren$$x0
000144698 980__ $$ajournal
000144698 980__ $$aVDB
000144698 980__ $$aI:(DE-He78)A102-20160331
000144698 980__ $$aUNRESTRICTED